Literature DB >> 22801760

Scar revision review.

J Regan Thomas1, Michael Somenek.   

Abstract

Scars are a natural part of dermal healing following lacerations, incisions, or tissue loss. They can vary in quality depending on the individual's racial characteristics, the mechanism of the trauma, and conditions in which the wound healed-all of which are factors beyond the surgeon's control. A scar on the face can have significant implications for the patient. What may seem like an insignificant issue to the casual observer can cause continuous frustration for the patient, affecting their daily lives. These can include psychological as well as social consequences, leading to a diminished quality of life. Factors that the surgeon can control include the favorable repositioning of the scar, proper alignment of the wound edges, and meticulous handling of the tissues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801760     DOI: 10.1001/archfacial.2012.223

Source DB:  PubMed          Journal:  Arch Facial Plast Surg        ISSN: 1521-2491


  8 in total

1.  Combination of medical needling and non-cultured autologous skin cell transplantation (renovacell) for repigmentation of hypopigmented burn scars in children and young people.

Authors:  K H Busch; R Bender; N Walezko; H Aziz; M A Altintas; M C Aust
Journal:  Ann Burns Fire Disasters       Date:  2016-06-30

2.  Angiotensin-converting enzyme inhibitor works as a scar formation inhibitor by down-regulating Smad and TGF-β-activated kinase 1 (TAK1) pathways in mice.

Authors:  Wei-Qiang Tan; Qing-Qing Fang; Xiao Z Shen; Jorge F Giani; Tuantuan V Zhao; Peng Shi; Li-Yun Zhang; Zakir Khan; You Li; Liang Li; Ji-Hua Xu; Ellen A Bernstein; Kenneth E Bernstein
Journal:  Br J Pharmacol       Date:  2018-10-08       Impact factor: 8.739

Review 3.  Bioengineered Wound Healing Skin Models: The Role of Immune Response and Endogenous ECM to Fully Replicate the Dynamic of Scar Tissue Formation In Vitro.

Authors:  Francesco Urciuolo; Roberta Passariello; Giorgia Imparato; Costantino Casale; Paolo Antonio Netti
Journal:  Bioengineering (Basel)       Date:  2022-05-27

Review 4.  Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions.

Authors:  Clement D Marshall; Michael S Hu; Tripp Leavitt; Leandra A Barnes; H Peter Lorenz; Michael T Longaker
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-02-01       Impact factor: 4.730

5.  Effects of different sutures on fibrosis and wound healing in a rabbit model of corneal wounds.

Authors:  Ying Li; Hui J Chen; Hua Zhang; Jian G Wu; Yun T Hu; Zhi Z Ma
Journal:  Exp Ther Med       Date:  2016-09-14       Impact factor: 2.447

6.  Angiotensin-converting enzyme inhibitor reduces scar formation by inhibiting both canonical and noncanonical TGF-β1 pathways.

Authors:  Qing-Qing Fang; Xiao-Feng Wang; Wan-Yi Zhao; Shi-Li Ding; Bang-Hui Shi; Ying Xia; Hu Yang; Li-Hong Wu; Cai-Yun Li; Wei-Qiang Tan
Journal:  Sci Rep       Date:  2018-02-20       Impact factor: 4.379

7.  The compound losartan cream inhibits scar formation via TGF-β/Smad pathway.

Authors:  Wan-Yi Zhao; Li-Yun Zhang; Gui-Da Xuan; Wei-Qiang Tan; Zheng-Cai Wang; Qing-Qing Fang; Xiao-Feng Wang; Yong-Zhong Du; Bang-Hui Shi; Dong Lou
Journal:  Sci Rep       Date:  2022-08-22       Impact factor: 4.996

8.  Low versus High Fluence Parameters in the Treatment of Facial Laceration Scars with a 1,550 nm Fractional Erbium-Glass Laser.

Authors:  Hyung-Sup Shim; Dai-Won Jun; Sang-Wha Kim; Sung-No Jung; Ho Kwon
Journal:  Biomed Res Int       Date:  2015-07-07       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.